{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:33:14Z","timestamp":1791891194399,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajem.2023.10.036","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:11:07Z","timestamp":1698444667000},"page":"90-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["High risk and low prevalence diseases: Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"75","author":[{"given":"Joshua","family":"Madden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ajem.2023.10.036_bb0005","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrneurol.2016.172","article-title":"Guillain-Barr\u00e9 syndrome: a century of progress","volume":"12","author":"Goodfellow","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain-Barr\u00e9 and fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ana.410400414","article-title":"Acute motor axonal neuropathy: an antibody-mediated attack on axolemma","volume":"40","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology."},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0025","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ajem.2023.10.036_bb0030","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/ene.13569","article-title":"Guillain-Barr\u00e9 syndrome in a local area in Japan, 2006-2015: an epidemiological and clinical study of 108 patients","volume":"25","author":"Matsui","year":"2018","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00007844","article-title":"Distinct pattern of age-specific incidence of Guillain-Barr\u00e9 syndrome in Harbin, China","volume":"249","author":"Cheng","year":"2002","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.ajem.2023.10.036_bb0040","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3201\/eid1707.101999","article-title":"High incidence of Guillain-Barre syndrome in children, Bangladesh","volume":"17","author":"Islam","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2023.10.036_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2014.05.065","article-title":"Guillain-Barr\u00e9 syndrome in Arab countries: a systematic review","volume":"343","author":"Benamer","year":"2014","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.ajem.2023.10.036_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007622","article-title":"Incidence of Guillain-Barr\u00e9 Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: a systematic review and meta-analysis","volume":"13","author":"Capasso","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.ajem.2023.10.036_bb0055","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1136\/jnnp-2014-309056","article-title":"Seasonal variation in Guillain-Barr\u00e9 syndrome: a systematic review, meta-analysis and Oxfordshire cohort study","volume":"86","author":"Webb","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"10.1016\/j.ajem.2023.10.036_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/brain\/118.3.597","article-title":"Guillain-Barr\u00e9 syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies","volume":"118","author":"Ho","year":"1995","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.ajem.2023.10.036_bb0065","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.ajem.2023.10.036_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pediatrneurol.2020.01.017","article-title":"Pediatric Guillain-Barr\u00e9 Syndrome in a 30-year Nationwide cohort","volume":"107","author":"Levison","year":"2020","journal-title":"Pediatr Neurol"},{"issue":"10280","key":"10.1016\/j.ajem.2023.10.036_bb0075","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet."},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0022-510X(91)90303-O","article-title":"Clinical signs in severe Guillain-Barr\u00e9 syndrome: analysis of 63 patients","volume":"104","author":"de Jager","year":"1991","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.ajem.2023.10.036_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0090","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ajem.2023.10.036_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.525699","article-title":"Case report: early-onset Guillain-Barre syndrome mimicking stroke","volume":"12","author":"Sun","year":"2021","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0100","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ana.410430424","article-title":"Preserved tendon reflexes in Campylobacter neuropathy","volume":"43","author":"Yuki","year":"1998","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jns.12469","article-title":"Antecedent infections in Guillain-Barr\u00e9 syndrome in endemic areas of arbovirus transmission: A multinational case-control study","volume":"26","author":"Leonhard","year":"2021","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0115","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1001\/jamaneurol.2017.1912","article-title":"Neurological complications associated with anti-programmed death 1 (PD-1) antibodies","volume":"74","author":"Kao","year":"2017","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/annonc\/mdw558","article-title":"Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single Centre experience and review of the literature","volume":"28","author":"Spain","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"issue":"8749","key":"10.1016\/j.ajem.2023.10.036_bb0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0140-6736(91)91767-O","article-title":"Motoneuron-disease-like disorder after ganglioside therapy","volume":"337","author":"Yuki","year":"1991","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ajem.2023.10.036_bb0135","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1007\/s00415-020-09742-2","article-title":"Axonal variants of Guillain-Barr\u00e9 syndrome: an update","volume":"268","author":"Shang","year":"2021","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0140","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain-Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology."},{"issue":"Suppl","key":"10.1016\/j.ajem.2023.10.036_bb0145","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000052111","article-title":"GBS-consensus group of the Dutch neuromuscular research support Centre. Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome","volume":"45","author":"Van der Mech\u00e9","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.ajem.2023.10.036_bb0155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(08)70215-1","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","volume":"7","author":"van Doorn","year":"2008","journal-title":"Lancet Neurol"},{"issue":"Pt 1","key":"10.1016\/j.ajem.2023.10.036_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain."},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0170","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1992.00530300044009","article-title":"Subacute idiopathic demyelinating polyradiculoneuropathy","volume":"49","author":"Hughes","year":"1992","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mus.24772","article-title":"Factors contributing to delay in diagnosis of Guillain-Barr\u00e9 syndrome and impact on clinical outcome","volume":"53","author":"Dubey","year":"2016","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0180","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.annemergmed.2005.05.008","article-title":"Guillain-Barr\u00e9 syndrome in the emergency department","volume":"47","author":"McGillicuddy","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0185","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4103\/0972-2327.104354","article-title":"Reversible electrophysiological abnormalities in acute secondary hyperkalemic paralysis","volume":"15","author":"Naik","year":"2012","journal-title":"Ann Indian Acad Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/0976-3147.118794","article-title":"Uncommon dyselectrolytemia complicating Guillain-Barr\u00e9 syndrome","volume":"4","author":"Saroja","year":"2013","journal-title":"J Neurosci Rural Pract"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0195","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jnnp.68.6.750","article-title":"Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study","volume":"68","author":"Duyff","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-139X.2008.00555.x","article-title":"Neuromuscular disease in the dialysis patient: an update for the nephrologist","volume":"22","author":"Krishnan","year":"2009","journal-title":"Semin Dial"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0205","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.47.3.813","article-title":"Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barr\u00e9 syndrome","volume":"47","author":"Gorson","year":"1996","journal-title":"Neurology"},{"issue":"18","key":"10.1016\/j.ajem.2023.10.036_bb0210","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barre syndrome","volume":"80","author":"van den Berg","year":"2013","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2023.10.036_bb0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2014.06.021","article-title":"The value of comparing mortality of Guillain-Barr\u00e9 syndrome across different regions","volume":"344","author":"Wong","year":"2014","journal-title":"J Neurol Sci"},{"issue":"12","key":"10.1016\/j.ajem.2023.10.036_bb0220","article-title":"Intensive care and treatment of severe Guillain-Barr\u00e9 Syndrome","author":"Shang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain-Barr\u00e9 Syndrome: prevalence, clinical Spectrum, and outcomes","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Neurocrit Care"},{"issue":"17","key":"10.1016\/j.ajem.2023.10.036_bb0230","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajem.2023.10.036_bb0235","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000200885","article-title":"An international perspective on preceding infections in Guillain-Barr\u00e9 syndrome: the IGOS-1000 cohort","volume":"99","author":"Leonhard","year":"2022","journal-title":"Neurology"},{"issue":"10027","key":"10.1016\/j.ajem.2023.10.036_bb0240","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/WNP.0000000000000862","article-title":"Clinical neurophysiology of Zika virus-related disorders of the peripheral nervous system in adults","volume":"39","author":"Gonz\u00e1lez-Salazar","year":"2022","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.ajem.2023.10.036_bb0250","doi-asserted-by":"crossref","first-page":"100578","DOI":"10.1016\/j.bbih.2022.100578","article-title":"Guillain-Barr\u00e9 syndrome associated with COVID-19: A systematic review","volume":"28","author":"Pimentel","year":"2023","journal-title":"Brain Behav Immun Health"},{"issue":"9","key":"10.1016\/j.ajem.2023.10.036_bb0255","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1468-1331.2012.03730.x","article-title":"Increased incidence of Guillain-Barr\u00e9 syndrome after surgery","volume":"19","author":"Gensicke","year":"2012","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.ajem.2023.10.036_bb0260","article-title":"Guillain-Barr\u00e9 Syndrome as a presenting symptom in breast cancer: the importance of considering paraneoplastic neurologic syndrome","volume":"13","author":"Madala","year":"2021","journal-title":"Cureus."},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12872-023-03261-4","article-title":"Guillain-Barre syndrome after myocardial infarction: a case report and literature review","volume":"23","author":"Wen","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jog.15116","article-title":"Guillain-Barr\u00e9 syndrome during pregnancy: a case series","volume":"48","author":"\u017ddraljevi\u0107","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"issue":"37","key":"10.1016\/j.ajem.2023.10.036_bb0275","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1016\/j.vaccine.2018.05.119","article-title":"Vaccine-preventable diseases, vaccines and Guillain-Barre\u2019 syndrome","volume":"37","author":"Principi","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0280","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12026-022-09316-6","article-title":"Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review","volume":"70","author":"Abolmaali","year":"2022","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0285","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00415-021-10404-0","article-title":"Guillain-Barr\u00e9 syndrome in patients treated with immune checkpoint inhibitors","volume":"268","author":"Fan","year":"2021","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/jns.12189","article-title":"Guillain-Barr\u00e9 syndrome in Bangladesh: validation of Brighton criteria","volume":"21","author":"Islam","year":"2016","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0295","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0032-1329196","article-title":"Guillain-Barr\u00e9 syndrome","volume":"32","author":"Arcila-Londono","year":"2012","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0300","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.ajem.2023.10.036_bb0305","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/mus.25992","article-title":"Prospective comparison of acute motor axonal neuropathy and acute inflammatory demyelinating polyradiculoneuropathy in 140 children with Guillain-Barr\u00e9 syndrome in India","volume":"57","author":"Kalita","year":"2018","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ajem.2023.10.036_bb0310","first-page":"512","article-title":"Miller Fisher\u2019s syndrome","volume":"32","author":"Teener","year":"2012","journal-title":"Semin Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0315","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mus.20875","article-title":"Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery","volume":"37","author":"Notturno","year":"2008","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0320","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/brain\/awq214","article-title":"Clinicopathological features of acute autonomic and sensory neuropathy","volume":"133","author":"Koike","year":"2010","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.ajem.2023.10.036_bb0325","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199204233261706","article-title":"The Guillain-Barr\u00e9 syndrome","volume":"326","author":"Ropper","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ajem.2023.10.036_bb0330","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.4103\/0972-2327.83087","article-title":"Treatment guidelines for Guillain-Barr\u00e9 Syndrome","volume":"14","author":"Meena","year":"2011","journal-title":"Ann Indian Acad Neurol"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12028-022-01457-8","article-title":"Risk factors for mechanical ventilation in patients with Guillain-Barr\u00e9 Syndrome","volume":"37","author":"Cheng","year":"2022","journal-title":"Neurocrit Care"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0340","first-page":"565","article-title":"Criteria for diagnosis of Guillain-Barr\u00e9 syndrome","volume":"3","year":"1978","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ajem.2023.10.036_bb0345","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s004150050505","article-title":"The frequency of clinical variants of Guillain-Barr\u00e9 syndrome in Ferrara, Italy","volume":"246","author":"Govoni","year":"1999","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0350","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ajem.2023.10.036_bb0355","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00415-017-8429-8","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome in children and validation of the Brighton criteria","volume":"264","author":"Roodbol","year":"2017","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0360","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00207454.2014.913588","article-title":"Pathophysiology and diagnosis of Guillain-Barr\u00e9 syndrome - challenges and needs","volume":"125","author":"Dash","year":"2015","journal-title":"Int J Neurosci"},{"issue":"9","key":"10.1016\/j.ajem.2023.10.036_bb0365","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1007\/s00415-021-10479-9","article-title":"Cerebrospinal fluid analysis in Guillain-Barr\u00e9 syndrome: value of albumin quotients","volume":"268","author":"Rath","year":"2021","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0370","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.exger.2012.01.008","article-title":"The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma","volume":"47","author":"Chen","year":"2012","journal-title":"Exp Gerontol"},{"issue":"396","key":"10.1016\/j.ajem.2023.10.036_bb0375","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2018.10.033","article-title":"Adult CSF total protein: higher upper reference limits should be considered worldwide. A web-based survey","author":"Bourque","year":"2019","journal-title":"J Neurol Sci"},{"issue":"4 Suppl","key":"10.1016\/j.ajem.2023.10.036_bb0380","first-page":"923","article-title":"Cranial nerve enhancement in the Guillain-Barr\u00e9 syndrome","volume":"16","author":"Fulbright","year":"1995","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.ajem.2023.10.036_bb0385","first-page":"25","article-title":"Spinal MRI findings of guillain-barr\u00e9 syndrome","volume":"3","author":"Alkan","year":"2009","journal-title":"J Radiol Case Rep"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0390","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archneur.58.6.871","article-title":"The challenge of respiratory dysfunction in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Hahn","year":"2001","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ajem.2023.10.036_bb0395","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12028-011-9575-y","article-title":"Vital capacity versus maximal inspiratory pressure in patients with Guillain-Barr\u00e9 syndrome and myasthenia gravis","volume":"17","author":"Prigent","year":"2012","journal-title":"Neurocrit Care"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0400","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barr\u00e9 syndrome","volume":"58","author":"Lawn","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ajem.2023.10.036_bb0405","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jocn.2020.01.032","article-title":"Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barr\u00e9 Syndrome","volume":"72","author":"Kalita","year":"2020","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0410","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-020-00742-z","article-title":"Early mechanical ventilation in patients with Guillain-Barr\u00e9 syndrome at high risk of respiratory failure: a randomized trial","volume":"10","author":"Melone","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0415","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1017\/S0317167100004790","article-title":"BiPAP in early guillain-barr\u00e9 syndrome may fail","volume":"33","author":"Wijdicks","year":"2006","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"10.1016\/j.ajem.2023.10.036_bb0420","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/jnnp.54.11.1018-a","article-title":"Suxamethonium is contraindicated in the Guillain-Barr\u00e9 syndrome","volume":"54","author":"Reilly","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ajem.2023.10.036_bb0425","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajhp\/60.7.694","article-title":"Cardiac arrest from succinylcholine-induced hyperkalemia","volume":"60","author":"Huggins","year":"2003","journal-title":"Am J Health-Syst Pharm"},{"issue":"5","key":"10.1016\/j.ajem.2023.10.036_bb0430","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00000542-199005000-00026","article-title":"Cardiac arrest after succinylcholine administration in a pregnant patient recovered from Guillain-Barr\u00e9 syndrome","volume":"72","author":"Feldman","year":"1990","journal-title":"Anesthesiology."},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0435","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0019-5049.68389","article-title":"Anaesthesia in a diagnosed ventricular septal defect with Guillain-Barr\u00e9 paediatric patient for video assisted thoracic surgery","volume":"54","author":"Tomar","year":"2010","journal-title":"Indian J Anaesth"},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0440","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4103\/ija.ija_1006_21","article-title":"Twin anaesthetic challenges in a patient recovered from Guillain-Barre syndrome","volume":"66","author":"Kundal","year":"2022","journal-title":"Indian J Anaesth"},{"issue":"8","key":"10.1016\/j.ajem.2023.10.036_bb0445","first-page":"200","article-title":"The use of Sugammadex in a patient with Guillain-Barre Syndrome: a case report","volume":"8","author":"Tezcan","year":"2017","journal-title":"Case Rep"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0450","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mus.880171004","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: a review","volume":"17","author":"Zochodne","year":"1994","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ajem.2023.10.036_bb0455","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.amjcard.2009.06.069","article-title":"Cardiovascular complications of the Guillain-Barr\u00e9 syndrome","volume":"104","author":"Mukerji","year":"2009","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.ajem.2023.10.036_bb0460","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-234184","article-title":"Guillain-Barr\u00e9 syndrome and posterior reversible leukoencephalopathy syndrome: a rare association","volume":"13","author":"Joshi","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ajem.2023.10.036_bb0470","doi-asserted-by":"crossref","first-page":"251","DOI":"10.12659\/AJCR.902668","article-title":"Guillain-Barr\u00e9 syndrome presenting with sinus node dysfunction and refractory shock","volume":"18","author":"Ha","year":"2017","journal-title":"Am J Case Rep"},{"issue":"1","key":"10.1016\/j.ajem.2023.10.036_bb0475","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12028-019-00781-w","article-title":"Dysautonomia in Guillain-Barr\u00e9 syndrome: prevalence, clinical Spectrum, and outcomes","volume":"32","author":"Chakraborty","year":"2020","journal-title":"Neurocrit Care"},{"issue":"9","key":"10.1016\/j.ajem.2023.10.036_bb0480","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2044.1990.tb14441.x","article-title":"Autonomic dysfunction and Guillain-Barr\u00e9 syndrome. The use of esmolol in its management","volume":"45","author":"Calleja","year":"1990","journal-title":"Anaesthesia"},{"issue":"11","key":"10.1016\/j.ajem.2023.10.036_bb0485","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/jnnp.44.11.983","article-title":"Autonomic dysfunction in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Tuck","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"17","key":"10.1016\/j.ajem.2023.10.036_bb0490","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group","volume":"326","author":"Van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"issue":"9047","key":"10.1016\/j.ajem.2023.10.036_bb0495","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Plasma exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome trial group","volume":"349","year":"1997","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0500","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Quality standards Subcommittee of the American Academy of neurology. Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the quality standards Subcommittee of the American Academy of neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.ajem.2023.10.036_bb0505","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ana.21976","article-title":"Prediction of respiratory insufficiency in Guillain-Barr\u00e9 syndrome","volume":"67","author":"Walgaard","year":"2010","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ajem.2023.10.036_bb0510","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.26312","article-title":"International validation of the Erasmus Guillain-Barr\u00e9 syndrome respiratory insufficiency score","volume":"91","author":"Doets","year":"2022","journal-title":"Ann Neurol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723005788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675723005788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:08:26Z","timestamp":1760026106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675723005788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":102,"alternative-id":["S0735675723005788"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2023.10.036","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High risk and low prevalence diseases: Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2023.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}